# GW PHARMACEUTICALS PLC (GWPH)

> Institutional ownership reported to the SEC as of Q2 2024, from Form 13F filings. Source: https://holderbook.com/stocks/GWPH/

- Reporting holders: 1
- Reported value: $8.2K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Strategic Investment Solutions, Inc. /IL](https://holderbook.com/funds/1960144-strategic-investment-solutions-inc-il/) | $8.2K | 38 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2024 | 1 | $8.2K |
| Q1 2022 | 1 | $24.0K |
| Q2 2021 | 1 | $3.0K |
| Q1 2021 | 297 | $5.5B |
| Q4 2020 | 275 | $3.1B |
| Q3 2020 | 274 | $2.6B |
| Q2 2020 | 299 | $3.3B |
| Q1 2020 | 285 | $2.5B |
| Q4 2019 | 315 | $2.9B |
| Q3 2019 | 315 | $3.3B |
| Q2 2019 | 328 | $5.0B |
| Q1 2019 | 322 | $4.3B |